Predictions
Vaxcyte Inc.
Start price
Target price
Perf. (%)
€49.20
24.06.23
24.06.23
€70.00
31.12.26
31.12.26
33.13%
05.06.24
05.06.24
Could be very worthwhile Investment >20% year
Zura Bio Ltd.
Start price
Target price
Perf. (%)
€9.25
24.06.23
24.06.23
€15.00
31.12.25
31.12.25
-58.27%
22:26
22:26
Could be very worthwhile Investment >20% year
Centessa Pharmaceuticals Plc
Start price
Target price
Perf. (%)
€5.80
24.06.23
24.06.23
€9.00
31.12.25
31.12.25
28.45%
05.06.24
05.06.24
Could be very worthwhile Investment >20% year
Context Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.14
24.06.23
24.06.23
€3.00
31.12.25
31.12.25
42.11%
05.06.24
05.06.24
Could be very worthwhile Investment >20% year
Friedrich Vorwerk Group SE
Start price
Target price
Perf. (%)
€11.12
23.06.23
23.06.23
-
23.06.24
23.06.24
64.39%
22:26
22:26
Agripower France S.a.
Start price
Target price
Perf. (%)
€5.16
10.06.23
10.06.23
-
10.06.24
10.06.24
-80.52%
05.06.24
05.06.24
Could be worthwhile Investment >10% per year
Weber Inc.
Start price
Target price
Perf. (%)
€13.20
25.10.22
25.10.22
€15.00
-
24.09.21
24.09.21
Could be worthwhile Investment >10% per year
Everfuel A/S
Start price
Target price
Perf. (%)
€4.14
10.01.22
10.01.22
€15.00
19.12.26
19.12.26
-79.26%
22:26
22:26
Could be worthwhile Investment >10% per year
Barry Callebaut AG
Start price
Target price
Perf. (%)
€21.00
29.12.21
29.12.21
€25.00
08.02.27
08.02.27
-27.18%
05.06.24
05.06.24
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Market Leader or Top 3
Small cyclical dependencies
Speakeasy Cannabis Club Ltd.
Start price
Target price
Perf. (%)
€0.31
23.12.21
23.12.21
-
27.02.26
27.02.26
-72.82%
18.03.23
18.03.23
Abrasilver Resource Corp.
Start price
Target price
Perf. (%)
€0.52
18.05.21
18.05.21
€1.50
19.12.24
19.12.24
-28.54%
21.05.24
21.05.24
Could be worthwhile Investment >10% per year
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.20
04.05.20
04.05.20
€2.00
07.11.25
07.11.25
-7.11%
22:26
22:26
Could be very worthwhile Investment >20% year
Innovative
Higher risks for its business